ArticleJHEP reports : innovation in hepatology2026
Mass spectrometry-based de novo sequencing reveals non-canonical neoantigens with antitumor efficacy in hepatocellular carcinoma.
Xiaohua Xing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.